%0 Journal Article
%T Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
%A Andre A. Konski
%A Benjamin Movsas
%A Christopher A. Peters
%A Colleen A. Lawton
%A David P. D'Souza
%A Deborah W. Bruner
%A Eric M. Horwitz
%A Gerald E. Hanks
%A I.-Chow Joe Hsu
%A James D. Cox
%A Jeff M. Michalski
%A Jennifer Moughan
%A Kenneth L. Zeitzer
%A Mack Roach
%A III
%A Mark V. Mishra
%A Matthew B. Parliament
%A Seth A. Rosenthal
%A Stephanie L. Pugh
%J Archive of "Advances in Radiation Oncology".
%D 2018
%R 10.1016/j.adro.2018.04.010
%X A meta-analysis of sociodemographic variables and their association with late (>180 days from start of radiation therapy[RT]) bowel, bladder, and clustered bowel and bladder toxicities was conducted in patients with high-risk (clinical stages T2c-T4b or Gleason score 8-10 or prostate-specific antigen level >20) prostate cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128023/